Christine DAMASE-MICHEL

Christine DAMASE-MICHEL is a Researcher at the University Toulouse III Paul Sabatier, affiliated with the Center for Epidemiology and Population Health Research (UMR 1295), a joint unit with Inserm. She leads epidemiological studies focusing on drug safety during pregnancy and maternal-child health. Her work involves analyzing large healthcare databases such as EFEMERIS and POMME to assess risks of medications on pregnancy outcomes, congenital anomalies, and long-term child health.

Her research interests include pharmacoepidemiology, maternal-fetal pharmacology, and public health policy. She collaborates on international projects like ConcePTION, addressing medication safety during pregnancy and breastfeeding. Key areas include antiretroviral therapies, antidepressants, NSAIDs, and antiepileptics in pregnancy.

Recent studies examine trends in polypharmacy during pregnancy, hypertensive disorders linked to SNRIs, and fetal risks of fosfomycin. She also investigates long-term effects of prenatal drug exposure via the POMME cohort. Her work informs healthcare guidelines and regulatory policies on medication use in vulnerable populations.

Christine has advised on projects like the EFEMEREYE study on ocular anomalies and contributed to core outcome sets for maternal multimorbidity research. Her lab, SPHERE (Study of Perinatal, Paediatric, and Adolescent Health), emphasizes translational epidemiology and clinical pharmacology.